Anatomical and visual outcomes of Retreatment with Intravitreal Dexamethasone Implant versus shifting to intravitreal Aflibercept for refractory Diabetic macular edema after an i - Egyptian Knowledge Bank

330342

Anatomical and visual outcomes of Retreatment with Intravitreal Dexamethasone Implant versus shifting to intravitreal Aflibercept for refractory Diabetic macular edema after an i

Article

Last updated: 05 Jan 2025

Overview Similar Items

Article

INTRACAMERAL INJECTION OF DEXAMETHASONE VERSUS INTRAVITREAL INJECTION OF RANIBIZUMAB IN THE TREATMENT OF DIABETIC MACULAR EDEMA IN PATIENTS UNDERGOING CATARACT SURGERY

Article

Comparisons of Ranibizumab Injection and Dexamethasone Implant in Macular Oedema Secondary to Central Retinal Vein Occlusion

Article

Diabetic macular edema: posterior subtenons versus intravitreal injection of steroids

Article

Intra-Vitreal Injection of Triamcinolone Acetonide versus Bevacizumab for Management of Diabetic Macular Edema after Phaco Emulsification

Article

Evaluation of Intravitreal Aflibercept Injection for Macular Edema Secondary to Retinal Vein Occlusion

Article

Posterior subtenon versus intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema

Article

Optical coherence tomography biomarkers after intravitreal anti-vascular endothelial growth factor for diabetic macular edema

Article

Study of Structural Changes in Diabetic Macular Edema by Spectral Domain Optical Coherent Tomography after Intravitreal Injection of Triamcinolone Acetonide

Article

Assessment of Macular and Choroidal Changes After Intravitreal Anti-VEGF Injections in Diabetic Patients with Diabetic Macular Edema

Article

Comparison of Aflibercept (Eylea®) with Ranibizumab (Lucentis®) in treatment of diabetic macular edema by Optical Coherence Tomography